Study on Pre-Thrombotic States in Complex Diseases

Yan Jiang
2013-01-01
Abstract:Objective To observe the changes of pre-thrombosis markers in pre-thrombotic states of complex diseases and discuss the characteristics of their own.Lay the foundation for the study of the common base.Methods Distribution the complex diseases into four groups,The tumor group,hypertension group,coronary heart disease group,used include the expression of CD62p on platelets,the level of plasma tissue plasminogen activator(t-PA)and its inhibiter(PAI-1),the level of endothelin(ET-1),activated partial thromboplastin time(APTT),fibrinogen(FIB),prothrombin time(PT)and thrombin time(TT),which were tested by using Flow Cytometer,ELISA method,radioimmunoassay method and auto coagulometer.Results Compared with the control group,the average expression of CD62P,the level of plasma PAI,the number of PLT,the level of FIB in complex disease group were significantly increased,there was a significant increase in the level of serum ET-1only in the tumor group(P 0.05).The level of t-PA and APTT in complex disease group was decreased(P 0.05).There were no significant changes in PT,TT and the average expression of CD41(P 0.05).There were no significant changes between disease groups(P 0.05).Conclusion The changes of pre-thrombosis markers in pre-thrombotic states of complex diseases in common and have different characteristics at the same time;the pre-thrombotic state is one of the probable common pathophysiological mechanisms of complex diseases.
What problem does this paper attempt to address?